Dear Doctor Letter (Rote-Hand-Brief) on Pletal® (cilostazol): New safety information
2013.05.02
Active substance: cilostazol
As the result of a review of the benefits and risks of cilostazol and in collaboration with the European Medicines Agency, the indications for medicinal products containing cilostazol have been restricted.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN